In a first, New Jersey awards stem-cell grants
By Philadelphia Inquirer,
Philadelphia Inquirer
| 12. 17. 2005
The state became the first in the nation yesterday to fund stem-cell research, awarding grants to 17 researchers at universities, nonprofit institutions and corporate labs.
The grants of up to $300,000 each fund two years of research and were made possible by a $5 million allocation in the $28 billion state budget that acting Gov. Richard J. Codey signed in July. The New Jersey Commission on Science and Technology chose the recipients from 71 applicants. The researchers will study both adult stem cells, culled from spinal-cord fluid, and embryonic stem cells, which are formed in the first days of pregnancy.
Although California voters approved a $3 billion bond for stem-cell research last year, that state has yet to award any money, making New Jersey the first state to fund stem-cell research.
The New Jersey State Senate approved legislation Thursday that would place a $350 million bond referendum for stem-cell research grants on the ballot in November, but the bill's fate in the Assembly is uncertain during the lame-duck legislative session
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
By David Jensen, The California Stem Cell Report | 03.26.2026
SACRAMENTO, Ca. -- California’s $12 billion stem cell and gene therapy program scored a historic first today, announcing that it had for the first time helped to finance a revolutionary treatment that will now be available to the general public...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...